AAAAAA

   
Results: 1-8 |
Results: 8
WEIGHT-LOSS IS A REVERSIBLE FACTOR IN THE PROGNOSIS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
Authors: SCHOLS AMWJ SLANGEN J VOLOVICS L WOUTERS EFM
Citation: Amwj. Schols et al., WEIGHT-LOSS IS A REVERSIBLE FACTOR IN THE PROGNOSIS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE, American journal of respiratory and critical care medicine, 157(6), 1998, pp. 1791-1797
ANTI-APOPTOTIC PHENOTYPE IS ASSOCIATED WITH DECREASED LOCO-REGIONAL RECURRENCE RATE IN BREAST-CANCER
Authors: JAGER JJ JANSEN RLH ARENDS JW JOOSTENACHJANIE S VOLOVICS L SCHOUTEN LJ DEJONG JMA VONMEYENFELDT MF BLIJHAM GH
Citation: Jj. Jager et al., ANTI-APOPTOTIC PHENOTYPE IS ASSOCIATED WITH DECREASED LOCO-REGIONAL RECURRENCE RATE IN BREAST-CANCER, European journal of cancer, 34, 1998, pp. 454-454
THE PROGNOSTIC-SIGNIFICANCE OF STEROID-RECEPTOR ACTIVITY IN TUMOR-TISSUES OF PATIENTS WITH PRIMARY BREAST-CANCER
Authors: HUPPERETS PS VOLOVICS L SCHOUTEN LJ JAGER JJ SCHOUTEN HC HILLEN HF BLIJHAM GH
Citation: Ps. Hupperets et al., THE PROGNOSTIC-SIGNIFICANCE OF STEROID-RECEPTOR ACTIVITY IN TUMOR-TISSUES OF PATIENTS WITH PRIMARY BREAST-CANCER, American journal of clinical oncology, 20(6), 1997, pp. 546-551
PROGNOSTIC-SIGNIFICANCE OF ETIOLOGIC RISK-FACTORS IN EARLY BREAST-CANCER
Authors: SCHOUTEN LJ HUPPERETS PSGJ JAGER JJ VOLOVICS L WILS JA VERBEEK ALM BLIJHAM GH
Citation: Lj. Schouten et al., PROGNOSTIC-SIGNIFICANCE OF ETIOLOGIC RISK-FACTORS IN EARLY BREAST-CANCER, Breast cancer research and treatment, 43(3), 1997, pp. 217-223
RELATION BETWEEN ENDOMETRIAL WAVE-LIKE ACTIVITY AND FECUNDABILITY IN SPONTANEOUS CYCLES
Authors: IJLAND MM EVERS JLH DUNSELMAN GAJ VOLOVICS L HOOGLAND HJ
Citation: Mm. Ijland et al., RELATION BETWEEN ENDOMETRIAL WAVE-LIKE ACTIVITY AND FECUNDABILITY IN SPONTANEOUS CYCLES, Fertility and sterility, 67(3), 1997, pp. 492-496
ADJUVANT CHEMO-HORMONAL THERAPY WITH CYCLOPHOSPHAMIDE, DOXORUBICIN AND 5-FLUOROURACIL (CAF) WITH OR WITHOUT MEDROXYPROGESTERONE ACETATE FORNODE-POSITIVE CANCER-PATIENTS - UPDATE AT 7-YEAR FOLLOW-UP
Authors: HUPPERETS P WILS J VOLOVICS L SCHOUTEN L FICKERS M BRON H SCHOUTEN H JAGER J DEJONG J BEEX L HILLEN H BLIJHAM G
Citation: P. Hupperets et al., ADJUVANT CHEMO-HORMONAL THERAPY WITH CYCLOPHOSPHAMIDE, DOXORUBICIN AND 5-FLUOROURACIL (CAF) WITH OR WITHOUT MEDROXYPROGESTERONE ACETATE FORNODE-POSITIVE CANCER-PATIENTS - UPDATE AT 7-YEAR FOLLOW-UP, Annals of oncology, 6(1), 1995, pp. 90-91
MAMMOGRAPHY IN THE FOLLOW-UP AFTER BREAST-CONSERVING TREATMENT IN CANCER OF THE BREAST - SUITABILITY FOR MAMMOGRAPHIC INTERPRETATION, VALIDITY AND INTEROBSERVER VARIATION
Authors: JAGER JJ LANGENDIJK JA DOHMEN JP SCHREUTELKAMP IL VOLOVICS L VANENGELSHOVEN JM DEJONG JM SCHOUTEN LJ HUPPERETS PS BLIJHAM GH
Citation: Jj. Jager et al., MAMMOGRAPHY IN THE FOLLOW-UP AFTER BREAST-CONSERVING TREATMENT IN CANCER OF THE BREAST - SUITABILITY FOR MAMMOGRAPHIC INTERPRETATION, VALIDITY AND INTEROBSERVER VARIATION, British journal of radiology, 68(811), 1995, pp. 754-760
ADJUVANT CHEMOHORMONAL THERAPY WITH CYCLOPHOSPHAMIDE, DOXORUBICIN AND5-FLUOROURACIL (CAF) WITH OR WITHOUT MEDROXYPROGESTERONE ACETATE FOR NODE-POSITIVE BREAST-CANCER PATIENTS
Authors: HUPPERETS PSGJ WILS J VOLOVICS L SCHOUTEN L FICKERS M BRON H SCHOUTEN HC JAGER J SMEETS J DEJONG J BLIJHAM GH
Citation: Psgj. Hupperets et al., ADJUVANT CHEMOHORMONAL THERAPY WITH CYCLOPHOSPHAMIDE, DOXORUBICIN AND5-FLUOROURACIL (CAF) WITH OR WITHOUT MEDROXYPROGESTERONE ACETATE FOR NODE-POSITIVE BREAST-CANCER PATIENTS, Annals of oncology, 4(4), 1993, pp. 295-301
Risultati: 1-8 |